Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

[1]  J. Reis-Filho,et al.  Novel and Classic Myoepithelial/Stem Cell Markers in Metaplastic Carcinomas of the Breast , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[2]  F. Schmitt,et al.  p63 expression in sarcomatoid/metaplastic carcinomas of the breast , 2003, Histopathology.

[3]  M. Salto‐Tellez,et al.  Reliability of Tissue Microarrays in Detecting Protein Expression and Gene Amplification in Breast Cancer , 2003, Modern Pathology.

[4]  J. Reis-Filho,et al.  p63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast , 2002, Journal of clinical pathology.

[5]  R. Tibshirani,et al.  Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome , 2022 .

[6]  J. Reis-Filho,et al.  p63 expression in normal skin and usual cutaneous carcinomas , 2002, Journal of cutaneous pathology.

[7]  U. Pastorino,et al.  p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? , 2002, The Journal of pathology.

[8]  D. Burstein,et al.  P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. , 2002, Human pathology.

[9]  J. Reis-Filho,et al.  Taking Advantage of Basic Research: p63 Is a Reliable Myoepithelial and Stem Cell Marker , 2002, Advances in anatomic pathology.

[10]  J. Reis-Filho,et al.  Naked nuclei revisited: p63 Immunoexpression , 2002, Diagnostic cytopathology.

[11]  W. Frankel,et al.  Cytokeratin 5/6 Immunostaining in Hepatobiliary and Pancreatic Neoplasms , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[12]  Hermann Herbst,et al.  Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept , 2002, Laboratory Investigation.

[13]  P. Chu,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[14]  J. Nesland,et al.  Differential Ki67 and bcl‐2 immunoexpression in solid–glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin , 2002, Histopathology.

[15]  F. Bootz,et al.  Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck , 2002, International journal of cancer.

[16]  E. Sturgis,et al.  Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. , 2002, Human pathology.

[17]  C. Cordon-Cardo,et al.  p63 expression profiles in human normal and tumor tissues. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  P. Chu,et al.  Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases , 2002, Modern Pathology.

[19]  T. Tot.  Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. , 2002, European journal of cancer.

[20]  M Dietel,et al.  Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. , 2001, American journal of clinical pathology.

[21]  R. Odze,et al.  Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. , 2001, Human pathology.

[22]  Misako Sato,et al.  Metaplastic Carcinoma of the Breast: p53 Analysis Identified the Same Point Mutation in the Three Histologic Components , 2001, Modern Pathology.

[23]  A. Ashworth,et al.  Microarray and histopathological analysis of tumours: the future and the past? , 2001, Nature Reviews Cancer.

[24]  Axel Hoos,et al.  Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations , 2001, Laboratory Investigation.

[25]  W. Gage,et al.  p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. , 2001, Urology.

[26]  H. Moch,et al.  Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies , 2001, The Journal of pathology.

[27]  G. Viale,et al.  p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast , 2001, The American journal of surgical pathology.

[28]  S. Lakhani,et al.  CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation , 2001, British Journal of Cancer.

[29]  L. Weiss,et al.  Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours , 2001, Histopathology.

[30]  G. Pelosi,et al.  Pulmonary Epithelial-Myoepithelial Tumor of Unproven Malignant Potential: Report of a Case and Review of the Literature , 2001, Modern Pathology.

[31]  B. Quade,et al.  Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. , 2001, Human pathology.

[32]  C. Cordon-Cardo,et al.  Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.

[33]  Holger Moch,et al.  Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology? , 2001, Advances in anatomic pathology.

[34]  F. McKeon,et al.  Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. , 2001, Gynecologic oncology.

[35]  D. Rimm,et al.  Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.

[36]  R Montironi,et al.  p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.

[37]  S. Lakhani,et al.  The mammary myoepithelial cell - Cinderella or ugly sister? , 2000, Breast Cancer Research.

[38]  R. Knight,et al.  p63 and p73 transactivate differentiation gene promoters in human keratinocytes. , 2000, Biochemical and biophysical research communications.

[39]  S. Lakhani,et al.  Comparative Genomic Hybridization Analysis of Myoepithelial Carcinoma of the Breast , 2000, Laboratory Investigation.

[40]  G Melino,et al.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions. , 2000, Journal of cell science.

[41]  J. Jen,et al.  AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  V. Eusebi,et al.  Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast , 2000, Breast Cancer Research.

[43]  A. Nicholson,et al.  Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura , 2000, Modern Pathology.

[44]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[45]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[46]  N. Ordóñez,et al.  Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. , 1998, The American journal of surgical pathology.

[47]  P. Maxwell,et al.  Cytokeratin intermediate filament expression in benign and malignant breast disease. , 1995, Journal of clinical pathology.

[48]  P. Bosco,et al.  Chromosomal assignments of human type I and type II cytokeratin genes to different chromosomes. , 1988, Cytogenetics and cell genetics.

[49]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.